Matrix-Applied Characterized Autologous Cultured Chondrocytes Versus Microfracture: Two-Year Follow-...
Matrix-Applied Characterized Autologous Cultured Chondrocytes Versus Microfracture: Two-Year Follow-up of a Prospective Randomized Trial
About this item
Full title
Author / Creator
SUMMIT study group , on behalf of the SUMMIT study group , Saris, Daniel , Price, Andrew , Widuchowski, Wojciech , Bertrand-Marchand, Marion , Caron, Jacob , Drogset, Jon Olav , Emans, Pieter , Podskubka, Ales , Tsuchida, Anika , Kili, Sven , Levine, David , Brittberg, Mats , Paša, Libor , Trc, Tomas , Slynarski, Konrad , Sanson, Bernd-Jan and Bezuidenhoudt, Mauritz
Publisher
Los Angeles, CA: SAGE Publications
Journal title
Language
English
Formats
Publication information
Publisher
Los Angeles, CA: SAGE Publications
Subjects
More information
Scope and Contents
Contents
Background:
Randomized controlled trials studying the efficacy and safety of matrix-applied characterized autologous cultured chondrocytes (MACI) versus microfracture (MFX) for treating cartilage defects are limited.
Purpose:
To compare the clinical efficacy and safety of MACI versus MFX in the treatment of patients with symptomatic cartil...
Alternative Titles
Full title
Matrix-Applied Characterized Autologous Cultured Chondrocytes Versus Microfracture: Two-Year Follow-up of a Prospective Randomized Trial
Authors, Artists and Contributors
Author / Creator
on behalf of the SUMMIT study group
Saris, Daniel
Price, Andrew
Widuchowski, Wojciech
Bertrand-Marchand, Marion
Caron, Jacob
Drogset, Jon Olav
Emans, Pieter
Podskubka, Ales
Tsuchida, Anika
Kili, Sven
Levine, David
Brittberg, Mats
Paša, Libor
Trc, Tomas
Slynarski, Konrad
Sanson, Bernd-Jan
Bezuidenhoudt, Mauritz
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_1705062637
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1705062637
Other Identifiers
ISSN
0363-5465
E-ISSN
1552-3365
DOI
10.1177/0363546514528093
